← All services

TLGS service vertical · H

Licensing, Permits & National Compliance

Coordinated licensing and operational-compliance support for multi-location healthcare, retail, industrial and logistics operations, with attention to the requirements of each activity and jurisdiction.

Specialist capability

Industrial Policy, Ports & Trade Regulatory Advisory

Evidence-led representations, specialist analysis and coordinated institutional engagement for companies and industry bodies facing systemic regulatory obstacles.

Explore the practice →

Specialist practice

Pharmaceutical & Healthcare Regulatory Affairs

Connect licensing, inspection readiness and national operational compliance with the relevant TLGS expertise.

Explore the healthcare regulatory practice →

Our work · Industrial policy & regulatory alignment

SBL & EMWA.
From industry representation
to a written policy outcome.

Completed policy and regulatory advisory for Special Blasts Limited, SBL Energy Limited and affected EMWA members, now documented alongside MoPSW’s 17 March 2026 removal of paragraph 2(v) of its ammonium nitrate port advisory. The engagement addressed an overnight-berthing constraint affecting industrial supply chains.

TLGS scope completed

Our work · Long-standing institutional engagement

Supporting Tata 1mg.
Across formats. Across India.

TLGS is a long-standing pan-India regulatory advisory and operational-compliance partner to Tata 1mg, supporting defined assignments across retail pharmacy, e-pharmacy, institutional healthcare and e-diagnostics.

Tata 1mgLong-standing institutional client of TLGS
Retail pharmacyE-pharmacyInstitutional healthcareE-diagnostics

Pan-India coordination · State-specific execution · Documented reporting

TLGS expertise

Relevant TLGS expertise

Meet our people →

Shri Rajesh P. Chaudhari

Former Assistant Commissioner, Food and Drugs Administration, Maharashtra State

Regional Principal Advisor

Pharmaceutical Regulatory Affairs, Licensing & Compliance (Maharashtra)

Financial approvals: Managing Director only

Former Assistant Commissioner, FDA Maharashtra, with more than three decades of experience in pharmaceutical regulation, licensing, inspections, quality systems and regulatory administration.

View profile

CS Sonal Jain

Fellow Company Secretary (FCS), Law Graduate & Independent DirectorCorporate governance, secretarial audit & POSH compliance

Board Affairs & Strategic Communication Lead

MD Office

Financial approvals: Managing Director only

Fellow Company Secretary and law graduate with over a decade of experience in corporate governance, secretarial audit, MCA/SEBI/FEMA compliance and POSH advisory, combining board-level perspective with professional training and strategic communication.

View profile

Bharat Pulse · Industrial policy

When a port circular becomes an industry-wide policy issue.

The SBL / EMWA case now includes MoPSW’s 17 March 2026 amendment: the removal of a specific port-advisory paragraph, the continuing safety framework and the commercial relevance of a documented policy correction.

Read the updated perspective →

Published 13 September 2026 · Updated 3 October 2026 with the official letters · Decision date: 17 March 2026.

Bharat Pulse · Healthcare regulatory insights

Public sources. Practical implications.

Dated regulatory notes with official references and a separately identified TLGS perspective.

All healthcare notes →
Maharashtra · TLGS Research

Hospital-linked pharmacies: patient choice belongs in the compliance workflow

A Maharashtra FDA order brings prescription access and patient choice into the operating controls of hospital-linked pharmacy services.

Official order · reviewed 13 September 2026

Read the sourced insight →
Maharashtra · TLGS Research

Maharashtra licensing: verify the application channel before a multi-location rollout

Current Maharashtra FDA portal guidance makes application-channel verification an important first step for new manufacturing and sales users.

Official portal guidance · reviewed 13 September 2026

Read the sourced insight →
India · TLGS Research

From drug-quality alerts to batch-level action across a pharmacy network

A central-government reply explains the public drug-alert process. For retail and e-pharmacy networks, the operating question is how an alert becomes a traceable, location-specific response.

Official parliamentary reply · reviewed 13 September 2026

Read the sourced insight →

These are independent TLGS sector notes, not Tata 1mg statements or findings about a client. Review dates are not announcement dates.

The scope of each engagement is agreed after review of the facts, documents, applicable framework and conflicts. Services are advisory and coordination-led; court appearances, reserved professional work and technical certifications are undertaken through appropriately authorised professionals. No court, regulatory, funding or commercial outcome is guaranteed.

From current developments to client work

Current sector applications.

Defined work programmes connected to TLGS’s existing practices and the evolving project and policy agenda.

Explore all sector applications →

This capability in practice

Selected TLGS work.

All related work →
Financial approvals: Managing Director only. No cash or personal-account payments for TLGS engagements. Verify & pay safely →